NCT00612859View on ClinicalTrials.gov

Study to Assess the Efficacy and Safety of Levetiracetam for the Treatment of Social Anxiety Disorder (Generalized Type)

PHASE2CompletedINTERVENTIONAL
Enrollment

217

Participants

Timeline

Start Date

September 30, 2003

Primary Completion Date

June 30, 2004

Study Completion Date

June 30, 2004

Conditions
Anxiety Disorders
Interventions
DRUG

levetiracetam

Sponsors

Lead Sponsor

UCB Pharma
All Listed Sponsors
lead

UCB Pharma

INDUSTRY

NCT00612859 - Study to Assess the Efficacy and Safety of Levetiracetam for the Treatment of Social Anxiety Disorder (Generalized Type) | Biotech Hunter | Biotech Hunter